Table 1.

CMV risk factors for solid organ transplant recipients

Serostatus	Mild risk	Moderate risk	High risk
D+/R–			XX
D+/R+		XX
D–/R+		X
D–/R–	X (from primary infection acquired in the community)
Transplanted organ
Lung			XX
Pancreas			XX
Intestinal			XX
Heart		X
Kidney		X
Liver		X
Induction immunotherapy
Alemtuzumab			XX
ATG			XX
Basiliximab		X
Maintenance immunosuppression
Calcineurin inhibitors/antimetabolites		X
Steroids			X
mTOR inhibitors	X
Mycophenolate mophetil		X (standard dose of =<2 g/day)	X (high dose of ≥3 g/day)

Notes: XX is higher risk than X for the same risk category

Risk factors for CMV in allogeneic hematopoietic stem cell transplant recipients are listed in the text.

Abbreviations: CMV cytomegalovirus; ATG, anti-thymocyte globulin, mTOR, mammalian target of rapamycin.